Figure 2. Effect of in vivo MDSC transplantation and NMES on CD31 positive cells in dystrophic muscles.

(A) Fold change in CD31+ cells on MDSC, PBS+NMES and MDSC+NMES groups, when compared to PBS injected controls (n = 5–6/group). (B) CD31 immunostaining in the tissue cross-sections of TA muscles across experimental groups (20× magnification). * Denotes significantly different when compared to MDSC 4 week (p<0.05).